These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29296657)

  • 1. Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].
    Martin M; Grisham RN; Turashvili G; Halpenny DF; Aghajanian CA; Makker V
    Gynecol Oncol Rep; 2017 Nov; 22():118. PubMed ID: 29296657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "Metastatic hepatoid carcinoma of ovarian origin - A case report from Northern Pakistan" [Gynecol. Oncol. Rep. 21 (2017) 24-27].
    Mahmood H; Fatima H; Faheem M
    Gynecol Oncol Rep; 2017 Nov; 22():117. PubMed ID: 29296656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
    Oh J; Barve M; Senzer N; Aaron P; Manning L; Wallraven G; Bognar E; Stanbery L; Horvath S; Manley M; Nemunaitis J; Walter A; Rocconi RP
    Gynecol Oncol Rep; 2021 May; 36():100740. PubMed ID: 34095420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002].
    Knisely A; Huang Y; Li Y; Prabhu VS; Wright JD
    Gynecol Oncol Rep; 2023 Apr; 46():101112. PubMed ID: 37082519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge" [Gynecol. Oncol. Rep. 37 (2021) 100848].
    Ashraf M; Goh WA; Tan EMX; Nadarajah R
    Gynecol Oncol Rep; 2021 Nov; 38():100861. PubMed ID: 34977315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
    Santin AD; Filiaci V; Bellone S; O'Cearbhaill R; Ratner ES; Mathews CA; Cantuaria G; Gunderson CC; Rutledge T; Buttin BM; Lankes HA; Birrer MJ
    Gynecol Oncol Rep; 2020 Aug; 33():100590. PubMed ID: 32885014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation.
    Martin M; Grisham RN; Turashvili G; Halpenny DF; Aghajanian CA; Makker V
    Gynecol Oncol Rep; 2017 Nov; 22():9-12. PubMed ID: 28932807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum regarding missing Declaration of Competing Interest statements in previously published articles.
    Gynecol Oncol Rep; 2021 Feb; 35():100704. PubMed ID: 33614878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum regarding missing Declaration of Competing Interest statements in previously published articles.
    Gynecol Oncol Rep; 2021 Feb; 35():100703. PubMed ID: 33614877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Why should radiation oncology do translational research?" [Rep Pract Oncol Radiother 2019;24(1):60-64].
    Cañas R; Linares I; Guedea F; Berenguer Francés MÁ
    Rep Pract Oncol Radiother; 2019; 24(2):151. PubMed ID: 30723386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway" [Gynecol Oncol. 2019 Jul;154(1):207-217. doi: 10.1016/j.ygyno.2019.04.005. Epub 2019 Apr 9].
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2024 Jan; 180():168-169. PubMed ID: 38091777
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
    López Torrecilla J; Hervás A; Zapatero A; Gómez Caamaño A; Macías V; Herruzo I; Maldonado X; Gómez Iturriaga A; Casas F; González San Segundo C
    Rep Pract Oncol Radiother; 2016; 21(1):90-2. PubMed ID: 26900365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous borderline tumor with distant mediastinal metastasis? An Exceptional presentation of ovarian tumor.
    Sołek JM; Zielińska A; Sobczak M; Czernek U; Kubiak R; Kordek R; Jesionek-Kupnicka D
    Pol J Pathol; 2021; 72(3):272-276. PubMed ID: 35048641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis.
    Veran-Taguibao S; Taguibao RAA; Gallegos N; Farzaneh T; Kim R; Lin F; Lu D
    Case Rep Pathol; 2019; 2019():2954373. PubMed ID: 31240144
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448.
    Cohen PA; Powell A; Böhm S; Gilks CB; Stewart CJR; Meniawy TM; Bulsara M; Avril S; Brockbank EC; Bosse T; de Azevedo Focchi GR; Ganesan R; Glasspool RM; Howitt BE; Kim HS; Lee JY; Le ND; Lockley M; Manchanda R; Mandalia T; McCluggage WG; McNeish I; Midha D; Srinivasan R; Tan YY; van der Griend R; Yunokawa M; Zannoni GF; ; Singh N
    Gynecol Oncol; 2021 Apr; 161(1):328-329. PubMed ID: 33551198
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" [Gynecol. Oncol. 154 (2019) 441-448].
    Cohen PA; Powell A; Böhm S; Gilks CB; Stewart CJR; Meniawy TM; Bulsara M; Avril S; Brockbank EC; Bosse T; de Azevedo Focchi GR; Ganesan R; Glasspool RM; Howitt BE; Kim HS; Lee JY; Le ND; Lockley M; Manchanda R; Mandalia T; McCluggage WG; McNeish I; Midha D; Srinivasan R; Tan YY; van der Griend R; Yunokawa M; Zannoni GF; ; Singh N
    Gynecol Oncol; 2020 May; 157(2):558-559. PubMed ID: 32087992
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Asymptomatic presentation of a congenital malformation of the portal vein with portosystemic shunt" [Radiol Case Rep 15 (2020) 2009-2014].
    Musa J; Madani K; Saliaj K; Cai J; Guy A; Saraci B; Kola E; Hyseni F; Saadi S; Ceka E
    Radiol Case Rep; 2020 Dec; 15(12):2718. PubMed ID: 33193927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Prostatic involvement in disseminated paracoccidioidomycosis: An unusual presentation mimicking malignant neoplasm" [Med. Mycol. Case Rep. 28 (2020) 46-48].
    de Paula Passarin N; Claudio Pereira AA; Passos BL; Gil CM; Preciliano Marques LN; Silveira GL; Bonafé S; Moreira Neto LJ
    Med Mycol Case Rep; 2020 Dec; 30():51. PubMed ID: 33364153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
    Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
    Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Evaluation of NF1 and RASA1 gene expression in endometriosis" [Eur J Obstetr Gynecol Reprod Biol X 15 (2022) 100152].
    Yarahmadi G; Dehghanian M; Sandoghsaz RS; Savaee M; Shamsi F; Mehrjardi MYV
    Eur J Obstet Gynecol Reprod Biol X; 2023 Mar; 17():100173. PubMed ID: 36506347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.